We partner with emerging biotech to build the supplier relationships, procurement infrastructure, and supply chain resilience that serious programs require to scale.
Early-stage biotech teams make decisions about suppliers, manufacturing partners, and supply chains with incomplete information and no dedicated operational capacity to manage the consequences. Nexaura is the partner that closes that gap — identifying the right partners, the right processes, and the right contingencies before they become urgent.
Where complexity is the norm, we bring clarity, connection, and the foresight to keep your program moving.
A rigorous, evidence-based selection process — from CDMOs and CROs to API manufacturers and analytical labs — so you engage the right partner first time.
Design and implement GxP-ready procurement infrastructure from scratch. One PO issued, one shipment received, one relationship to manage.
Map single-source dependencies and geopolitical exposure, pre-qualify alternatives, and build contingency strategies before disruption forces your hand.
Most of our engagements begin at a specific inflection point — a moment when the cost of a misstep becomes materially higher, and the team does not yet have dedicated operational capacity in place.
Selecting the right CDMO, CMO, or analytical partner before the program's first clinical-grade campaign — when the cost of getting it wrong is measured in months.
Building operational infrastructure to support scale-up and meet investor expectations — without diluting the founding team's focus on the science.
Identifying and mitigating single-source risks, geopolitical dependencies, and material shortages before they become program-threatening events.
Ensuring procurement and supply chain documentation meets GxP and CMC requirements well ahead of the first regulatory conversation.
We are an independent advisory firm with scientific depth, operational experience across the full drug development value chain, and a model built entirely around your outcomes.
Every engagement is led by someone who has built and run these functions inside drug development companies — PhD-level scientific training paired with a decade of supply chain, clinical operations and procurement execution.
We map risks, second sources and operational gaps ahead of the crisis. Our recommendations identify the question behind the question your team is currently asking.
No supplier affiliations. No placement fees. No referral commissions. Our recommendations reflect the best fit for your program — nothing else.
We understand lean teams, high stakes, and the absence of room for costly missteps. Our engagement model scales with your organisation — not the other way around.
Building a biopharma company is hard enough without having to figure out your supply chain from scratch. Nexaura exists because early-stage teams deserve an operational partner who has actually done the work — not another directory.
A decade across the full drug development value chain — from immuno-oncology discovery, through CAR-T clinical operations at Johnson & Johnson, to leading the translational R&D build-out at Surge. PhD in medicinal chemistry, advanced training in AI and drug sciences.
Read the full story